# Ceftriaxone

## Cefin inj 2gm

| TAH Drug Code      | [ICEFI2](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ICEFI2)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Actinomycosis， severe or extensive ?Bite wound infection， treatment ?Bloodstream infection ?Chronic obstructive pulmonary disease， acute exacerbation ?Diabetic foot infection， moderate to severe ?Endocarditis， prophylaxis ?Endocarditis， treatment ?Intra-abdominal infection， mild to moderate， community acquired in patients without risk factors for resistance or treatment failure ?Intracranial abscess or spinal epidural abscess ?Lyme disease ?Meningitis， bacterial ?Meningococcal disease， chemoprophylaxis after close contact with high-risk patient ?Neurobrucellosis ?Odontogenic soft tissue infection， pyogenic ?Osteomyelitis and/or discitis ?Otitis media， acute ?Peritonitis， treatment， peritoneal dialysis ?Pneumonia， community acquired ?Prostatitis， acute bacterial ?Prosthetic joint infection ?Rat bite fever ?Salmonella species infection ?Septic arthritis ?Sexually transmitted infections ?Skin and soft tissue infection ?Spontaneous bacterial peritonitis ?Surgical prophylaxis， colorectal ?Toxic shock syndrome， streptococcal ?Urinary tract infection， complicated Vibrio vulnificus infection                                                                                                                                                                                                                                                                                                                                              |
| Dosing             | Bloodstream infection/Intra-abdominal infection， mild to moderate， community acquired in patients without risk factors for resistance or treatment failure/Otitis media， acute (alternative agent for patients with nonsevere， non-IgE-mediated penicillin allergy)/Pneumonia， community acquired/Skin and soft tissue infection: IV: 1 to 2 g once daily. Meningitis， bacterial: IV: 2 g every 12 hours. Osteomyelitis and/or discitis/Prosthetic joint infection/Septic arthritis: IV: 2 g every 24 hours. Sexually transmitted infections: IM: 500 mg (1 g in patients ?150 kg) as a single dose. Surgical prophylaxis， colorectal (alternative agent): IV: 2 g within 60 minutes prior to surgical incision in combination with metronidazole. Urinary tract infection， complicated: IV， IM: 1 g once.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Contraindications  | Hypersensitivity to ceftriaxone， any component of the formulation， or other cephalosporins; do not use in hyperbilirubinemic neonates， particularly those who are premature since ceftriaxone is reported to displace bilirubin from albumin binding sites; concomitant use with intravenous calcium-containing solutions/products in neonates (?28 days); IV use of ceftriaxone solutions containing lidocaine.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Adverse Effects    | >10%: Dermatologic: Skin tightness (IM; local) Local: Induration at injection site (incidence higher with IM)， warm sensation at injection site (IM) 1% to 10%: Dermatologic: Skin rash (2%) Gastrointestinal: Diarrhea (3%) Hematologic & oncologic: Eosinophilia (6%)， leukopenia (2%)， thrombocytosis (5%) Hepatic: Increased serum alanine aminotransferase (3%)， increased serum aspartate aminotransferase (3%) Local: Pain at injection site (?1%)， tenderness at injection site (?1%) Renal: Increased blood urea nitrogen (1%) <1%: Cardiovascular: Flushing， palpitations， phlebitis Dermatologic: Diaphoresis， pruritus Gastrointestinal: Abdominal pain， cholelithiasis， Clostridioides difficile colitis， dysgeusia， dyspepsia， flatulence， gallbladder sludge， nausea， vomiting Genitourinary: Glycosuria， hematuria， vaginitis Hematologic & oncologic: Agranulocytosis， anemia， basophilia， decreased prothrombin time， granulocytopenia， hemolytic anemia， lymphocytopenia， lymphocytosis， monocytosis， neutropenia， prolonged prothrombin time， thrombocytopenia Hepatic: Increased serum alkaline phosphatase， increased serum bilirubin， jaundice Hypersensitivity: Anaphylaxis， serum sickness Infection: Candidiasis Local: Injection-site phlebitis Nervous system: Chills， dizziness， headache， seizure Renal: Casts in urine， increased serum creatinine， nephrolithiasis Respiratory: Bronchospasm， epistaxis， hypersensitivity pneumonitis |
| Pregnancy          | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Lactation          | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| More Info          | [UpToDate](https://www.uptodate.com/contents/ceftriaxone-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |

## Ceft-S inj 1gm

| TAH Drug Code      | [ICEFS](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ICEFS)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Infections caused by staphylococcus， streptococcus， pneumococcus， meningococcus， and other susceptible bacteria.                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Dosing             | For adults: 1-2g once daily. Severe infections: maximum 4g/day， divided into two doses. For neonates (up to 2 weeks old): 20-50mg/kg/day， maximum 50mg/kg. For infants and children (3 weeks-12 years old): 20-80mg/kg/day， administered once daily. (Sanford Guide) Adult - Usual: 1-2g IV q24h. Purulent meningitis: 2g IV q12h. Gonococcal urethritis: single dose of 500mg IM (if <150kg)， 1g IM (if >=150kg). Meningococcal PEP (age >=15): single dose of 250 mg IM Pediatric - Age >28 Days: 50-100mg/kg q24h; Meningitis 50mg/kg q12h. Meningococcal PEP (age <15): 125mg IM x 1 dose |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Contraindications  | Concurrent administration of calcium-containing IV solutions， including continuous calcium-containing infusions such as parenteral nutrition， in neonates aged 28 days or less due to risk of fatal salt precipitation in lungs and kidneys. Hyperbilirubinemic neonates， due to increased risk of bilirubin encephalopathy (kernicterus)， especially in premature neonates. Hypersensitivity to cephalosporins. Pregnant women， especially during the first three months， should avoid using unless absolutely necessary.                                                                  |
| Adverse Effects    | Common: Injection site induration， Warmth， tightness， or induration (5-17%)， Diarrhea (2.7-5.6%)， Eosinophil count above reference range (6%)， Thrombocytosis (5.1%) Serious: Erythema multiforme， Stevens-Johnson syndrome， Toxic epidermal necrolysis， Clostridium difficile colitis， Hemolytic anemia (<1%)， Neutropenia， Hypersensitivity reaction (2.7-3.3%)， Kernicterus of newborn， Renal failure， Injury of lung                                                                                                                                                           |
| Pregnancy          | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Lactation          | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| More Info          | [UpToDate](https://www.uptodate.com/contents/ceftriaxone-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |

